Shanghai Junshi Biosciences Co Ltd
SSE:688180
Income Statement
Earnings Waterfall
Shanghai Junshi Biosciences Co Ltd
Revenue
|
1.5B
CNY
|
Cost of Revenue
|
-634.4m
CNY
|
Gross Profit
|
868.2m
CNY
|
Operating Expenses
|
-3.3B
CNY
|
Operating Income
|
-2.5B
CNY
|
Other Expenses
|
196m
CNY
|
Net Income
|
-2.3B
CNY
|
Income Statement
Shanghai Junshi Biosciences Co Ltd
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
1 595
N/A
|
3 038
+90%
|
3 134
+3%
|
3 302
+5%
|
4 025
+22%
|
3 039
-24%
|
2 856
-6%
|
2 525
-12%
|
1 453
-42%
|
1 079
-26%
|
1 177
+9%
|
1 222
+4%
|
1 503
+23%
|
|
Gross Profit | ||||||||||||||
Cost of Revenue |
(377)
|
(642)
|
(755)
|
(922)
|
(1 258)
|
(1 139)
|
(1 096)
|
(931)
|
(526)
|
(435)
|
(464)
|
(431)
|
(634)
|
|
Gross Profit |
1 218
N/A
|
2 396
+97%
|
2 380
-1%
|
2 381
+0%
|
2 767
+16%
|
1 901
-31%
|
1 761
-7%
|
1 594
-9%
|
927
-42%
|
644
-31%
|
713
+11%
|
791
+11%
|
868
+10%
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(2 896)
|
(3 390)
|
(3 455)
|
(3 356)
|
(3 361)
|
(3 348)
|
(3 391)
|
(3 578)
|
(3 646)
|
(3 582)
|
(3 549)
|
(3 271)
|
(3 348)
|
|
Selling, General & Administrative |
(1 068)
|
(1 411)
|
(1 471)
|
(1 389)
|
(1 273)
|
(1 283)
|
(1 260)
|
(1 354)
|
(1 179)
|
(1 243)
|
(1 293)
|
(1 267)
|
(1 338)
|
|
Research & Development |
(1 734)
|
(2 011)
|
(2 016)
|
(1 991)
|
(1 988)
|
(2 129)
|
(2 184)
|
(2 282)
|
(2 269)
|
(2 401)
|
(2 271)
|
(2 019)
|
(1 813)
|
|
Depreciation & Amortization |
(112)
|
0
|
0
|
0
|
(191)
|
0
|
0
|
0
|
(232)
|
0
|
0
|
0
|
(243)
|
|
Other Operating Expenses |
18
|
32
|
32
|
24
|
91
|
63
|
52
|
59
|
33
|
62
|
15
|
15
|
47
|
|
Operating Income |
(1 678)
N/A
|
(994)
+41%
|
(1 075)
-8%
|
(975)
+9%
|
(594)
+39%
|
(1 448)
-144%
|
(1 630)
-13%
|
(1 984)
-22%
|
(2 719)
-37%
|
(2 938)
-8%
|
(2 836)
+3%
|
(2 480)
+13%
|
(2 479)
+0%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
19
|
18
|
112
|
121
|
35
|
44
|
(54)
|
(34)
|
2
|
17
|
(5)
|
(42)
|
(138)
|
|
Non-Reccuring Items |
3
|
2
|
3
|
3
|
1
|
0
|
32
|
32
|
51
|
0
|
(9)
|
(9)
|
160
|
|
Gain/Loss on Disposition of Assets |
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
|
Total Other Income |
(16)
|
(15)
|
(12)
|
(5)
|
(37)
|
(33)
|
(31)
|
(24)
|
(11)
|
(14)
|
(15)
|
(28)
|
(34)
|
|
Pre-Tax Income |
(1 672)
N/A
|
(989)
+41%
|
(973)
+2%
|
(857)
+12%
|
(595)
+31%
|
(1 436)
-141%
|
(1 683)
-17%
|
(2 010)
-19%
|
(2 677)
-33%
|
(2 935)
-10%
|
(2 864)
+2%
|
(2 558)
+11%
|
(2 492)
+3%
|
|
Net Income | ||||||||||||||
Tax Provision |
4
|
(73)
|
(87)
|
(89)
|
(136)
|
(93)
|
(56)
|
(63)
|
93
|
132
|
153
|
153
|
(44)
|
|
Income from Continuing Operations |
(1 669)
|
(1 062)
|
(1 060)
|
(945)
|
(731)
|
(1 529)
|
(1 739)
|
(2 073)
|
(2 584)
|
(2 803)
|
(2 711)
|
(2 405)
|
(2 536)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
10
|
34
|
97
|
149
|
196
|
267
|
238
|
205
|
252
|
|
Net Income (Common) |
(1 669)
N/A
|
(1 062)
+36%
|
(1 060)
+0%
|
(945)
+11%
|
(721)
+24%
|
(1 495)
-107%
|
(1 643)
-10%
|
(1 924)
-17%
|
(2 388)
-24%
|
(2 535)
-6%
|
(2 473)
+2%
|
(2 200)
+11%
|
(2 283)
-4%
|
|
EPS (Diluted) |
-2.03
N/A
|
-1.21
+40%
|
-1.06
+12%
|
-1.03
+3%
|
-0.81
+21%
|
-1.64
-102%
|
-1.81
-10%
|
-2.12
-17%
|
-2.6
-23%
|
-2.57
+1%
|
-2.5
+3%
|
-2.24
+10%
|
-2.32
-4%
|